Skip to content

Every lot HPLC-tested · Certificate you can verify by lot number

RUO
LGD4033 - 10mg | 20mg

Research Chemicals

LGD4033 - 10mg | 20mg

HPLC testedIn stock · ships today

Purity is published only against a lot-matched COA.

Strength

StrengthUnit£/mgSave
10mg£46.99£4.70
20mg£55.99£2.80−40%

Qty

1

Total

£46.99

In stock · ships today

Research use only · Not for human or veterinary use

Guaranteed safe checkoutVISAMASTERCARDAMEX
Third-party HPLC tested
Certificate for every lot
Tracked, discreet shipping
Secure checkout
Research use only • Not for human or veterinary use
Selective androgen receptor research material

Grindlab LGD-4033

Supplied under the Grindlab LGD-4033 naming in two clearly labelled capsule products, 10 mg and 20 mg. Each option is presented as a separately labelled bottle of 60 capsules, and each submitted sample carries its own Janoshik laboratory report shown in full below.

From£46.99
Capsules 10 mg · 20 mg Janoshik tested
Grindlab LGD-4033 capsules in labelled 10mg and 20mg research bottles
10 mg capsule10 mgreported amount per tested capsule
20 mg capsule20 mgreported amount per tested capsule
Documentation2 reportsseparate Janoshik documents
ScopeRUOno human or veterinary use
Product information

Two documented capsule products

The supplied product and report information describes two separate LGD-4033 capsule products, labelled 10 mg and 20 mg, with 60 capsules stated for each bottle. Each option is displayed as a separately labelled research material alongside its own Janoshik document.

Product option 10 mg Supplied as a bottle containing 60 capsules, with a reported amount of 10 mg per tested capsule.
Product option 20 mg Supplied as a bottle containing 60 capsules, with a reported amount of 20 mg per tested capsule.
Material format Capsules Both options are presented in capsule format under the Grindlab LGD-4033 naming, each as a separately labelled research material.
Product documentation

Supplied report details presented clearly

Product details and laboratory documents are displayed together for each option without adding unsupported purity, consistency, quality-control or batch-wide claims. Product labels, reported amounts, bottle quantity and identified material are shown as recorded.

01

Separate product options

The 10 mg and 20 mg products are displayed separately, each with its 60-capsule bottle quantity and its associated laboratory report.
02

Reported identity

The supplied report information identifies both submitted samples as LGD-4033.
03

Reported amounts

The supplied information states 10 mg and 20 mg per tested capsule for the respective samples.
Documentation overview

Product information and report access

The available product details and laboratory documents can be reviewed together in one place, with each result tied to its submitted capsule sample.

01

Products listed

The 10 mg and 20 mg capsule products are displayed as separate options.
02

Samples identified

Both submitted samples are identified as LGD-4033 in the supplied information.
03

Amounts reported

The documents state a reported amount for each tested capsule sample.
04

Scope stated

Each result relates to its submitted laboratory sample and does not imply testing of every capsule.
Laboratory documentation

Grindlab LGD-4033 reports

Separate Janoshik laboratory documents are displayed below for the submitted 10 mg and 20 mg LGD-4033 capsule samples.

LGD-4033 10 mg report

Sample LGD-4033 10 mg
Client Grindlab
Identified as LGD-4033
Reported amount 10 mg / capsule
Bottle quantity 60 capsules
Product format Capsules
Task number Not supplied
Laboratory Janoshik
Result scope Submitted sample
Grindlab LGD-4033 10mg Janoshik laboratory report
Supplied Janoshik laboratory documentation for the submitted Grindlab LGD-4033 10 mg sample.

LGD-4033 20 mg report

Sample LGD-4033 20 mg
Client Grindlab
Identified as LGD-4033
Reported amount 20 mg / capsule
Bottle quantity 60 capsules
Product format Capsules
Task number Not supplied
Laboratory Janoshik
Result scope Submitted sample
Grindlab LGD-4033 20mg Janoshik laboratory report
Supplied Janoshik laboratory documentation for the submitted Grindlab LGD-4033 20 mg sample.
Product questions

Frequently asked questions

Which products are available?
Grindlab LGD-4033 is available as separately labelled 10 mg and 20 mg capsule products, each displayed with its own bottle quantity and laboratory report.
How many capsules are included?
Each selected bottle is described as containing 60 capsules for both the 10 mg and 20 mg options.
What format is the material supplied in?
Both available products are supplied in capsule format under the Grindlab LGD-4033 naming.
Are separate laboratory reports available?
Yes. Separate Janoshik laboratory documents are displayed for the 10 mg and 20 mg products.
What amounts are reported?
The supplied information states 10 mg per tested capsule for the 10 mg sample and 20 mg per tested capsule for the 20 mg sample.
Are laboratory task numbers available?
No laboratory task numbers were included in the information supplied for this page.
Does each result apply to every capsule?
Each displayed result relates to its submitted laboratory sample. The supplied information does not establish that every capsule in either bottle was individually tested.

Research use only

Grindlab LGD-4033 is supplied solely as a laboratory research material. It is not intended for human or veterinary consumption, administration, diagnosis, treatment, hormonal modification, body-composition alteration, physique alteration or performance enhancement. No representation is made regarding purity, batch-wide consistency, safety or effectiveness in humans.

Related compounds

From £46.99

Add to order